M. Baldus et al., A CASE OF PURE RED-CELL APLASIA - FOLLOW-UP ON DIFFERENT IMMUNOSUPPRESSIVE REGIMENS, The Clinical investigator, 72(12), 1994, pp. 1051-1055
A 66-year-old patient was admitted to our hospital in January 1992 for
further evaluation of severe normocytic anemia. Hemoglobin (Hb) was 3
.5 g/dl, reticulocyte count 1 parts per thousand. Bone marrow showed a
nearly complete lack of red cell precursors, thus favoring the diagno
sis of acquired pure red cell aplasia (PRCA). Immunosuppressive therap
y with prednisolone was started but had to be supplemented with azathi
oprine because of a further rapid decrease in Hb to 3.7 g/dl after an
initial transfusion of 6 U red blood cells. However, with this regimen
a renewed decrease in Hb to 6.6 g/dl was noted, and further transfusi
ons were required. Therefore therapy was switched to cyclosporine A (C
yA) while tapering off prednisolone. Four months after the initial dia
gnosis a positive parvovirus B19 IgM antibody was found. After the fai
lure of hematological remission with three immunosuppressive regimens
a course of high-dose intravenous immunoglobulins (IVIG) was administe
red in July 1992. Six weeks after IVIG therapy a peak hemoglobin conce
ntration of 12.3 g/dl was noted, and further transfusion was not requi
red. CyA was tapered off in October 1992. One month later CyA was rein
stituted because of a relapse of PRCA but was unsuccessful until Janua
ry 1993. At this time immunosuppressive CyA therapy was discontinued b
ecause of a periodontal abscess. In February 1993 a second IVIC infusi
on was given, and a second remission of PRCA was noted, showing an inc
rease in hemoglobin up to 14.5 g/dl by November 1993. At the last foll
ow-up visit in February 1994 our patient was still in complete hematol
ogical remission.